JPH07116200B2 - Cephalosporin manufacturing method - Google Patents
Cephalosporin manufacturing methodInfo
- Publication number
- JPH07116200B2 JPH07116200B2 JP60206231A JP20623185A JPH07116200B2 JP H07116200 B2 JPH07116200 B2 JP H07116200B2 JP 60206231 A JP60206231 A JP 60206231A JP 20623185 A JP20623185 A JP 20623185A JP H07116200 B2 JPH07116200 B2 JP H07116200B2
- Authority
- JP
- Japan
- Prior art keywords
- acid
- compound
- methyl
- salt
- dioxane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Landscapes
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Cephalosporin Compounds (AREA)
Description
【発明の詳細な説明】 [産業上の利用分野] 本発明は、次の化学式 で表わされる化合物(シン異性体)またはその塩を工業
的に高収率かつ高純度で製造する方法に関する。DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention has the following chemical formula: The present invention relates to a method for industrially producing a compound (syn isomer) or a salt thereof with high yield and high purity.
[従来の技術] 優れた抗菌スペクトルを有し、グラム陽性菌およびグラ
ム陰性菌に優れた抗菌活性を示す抗菌剤として有用な化
学式[IV]で表わされる化合物(シン異性体)およびそ
の塩並びにその製造法は、特開昭57-99592号に開示され
ている。[Prior Art] A compound (syn isomer) represented by the chemical formula [IV] having an excellent antibacterial spectrum and useful as an antibacterial agent showing excellent antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, salts thereof, and salts thereof The manufacturing method is disclosed in JP-A-57-99592.
[発明が解決しようとする問題点] しかしながら、これを工業的に実施するには、さらに優
れた製造方法が求められていた。[Problems to be Solved by the Invention] However, in order to carry out this industrially, a further excellent manufacturing method was required.
[問題を解決するための手段] 本発明者らは、上記問題点を解決すべく鋭意研究を重ね
た結果、一般式 [式中、Xはハロゲン原子を表わす。] で表わされる化合物(シン異性体)またはその塩と化学
式 で表わされる化合物もしくはその塩またはそれらの反応
性誘導体とを反応させた後、脱水反応に付し、ついで、
ジオキサンで処理して化学式[III]で表わされる化合
物(シン異性体)を単離し、ついで、このものからジオ
キサンを脱離すれば、化学式[IV]で表わされる化合物
(シン異性体)またはその塩が高収率でかつ高純度に得
られること、さらに化学式[III] で表わされるジオキサン付加化合物(シン化合物)が上
記製造法の中間体として有用であることを見出し、本発
明を完成するに至った。[Means for Solving the Problem] As a result of earnest studies to solve the above problems, the present inventors have found that the general formula [In the formula, X represents a halogen atom. ] The compound (syn isomer) represented by or its salt and chemical formula After reacting with a compound represented by or a salt thereof or a reactive derivative thereof, dehydration reaction is carried out, and then,
The compound represented by the chemical formula [III] (syn isomer) is isolated by treating with dioxane, and then the dioxane is eliminated from the compound, whereby the compound represented by the chemical formula [IV] (syn isomer) or a salt thereof. Can be obtained in high yield and high purity, and further has the chemical formula [III] The inventors have found that the dioxane addition compound (syn compound) represented by is useful as an intermediate in the above-mentioned production method, and completed the present invention.
以下、本発明を詳細に説明する。Hereinafter, the present invention will be described in detail.
式[I]、[II]、[IV]または[V]で表わされる化
合物の塩としては、従来ペニシリンおよびセファロスポ
リン系化合物の分野で周知の塩基性基または酸性基にお
ける塩が挙げられる。塩基性基における塩としては、た
とえば、塩酸、臭化水素酸、ヨウ化水素酸、硝酸、硫酸
などの鉱酸との塩;シュウ酸、コハク酸、ギ酸、トリク
ロロ酢酸、トリフルオロ酢酸などの有機カルボン酸との
塩;メタンスルホン酸、エタンスルホン酸、ベンゼンス
ルホン酸、トルエン−2−スルホン酸、トルエン−4−
スルホン酸、メシチレンスルホン酸、(2,4,6−トリメ
チルベンゼンスルホン酸)などのスルホン酸との塩が挙
げられ、また酸性基における塩としては、たとえば、ナ
トリウム、カリウムなどのアルカリ金属との塩;カルシ
ウム、マグネシウムなどのアルカリ土類金属との塩;ア
ンモニウム塩;トリエチルアミン、トリメチルアミン、
アニリン、N,N−ジメチルアニリン、ピリジン、ジシク
ロヘキシルアミンなどの含窒素有機塩基との塩が挙げら
れる。Examples of the salt of the compound represented by the formula [I], [II], [IV] or [V] include salts in a basic group or an acidic group well known in the art of penicillin and cephalosporin compounds. Examples of the salt in the basic group include salts with mineral acids such as hydrochloric acid, hydrobromic acid, hydroiodic acid, nitric acid and sulfuric acid; organic acids such as oxalic acid, succinic acid, formic acid, trichloroacetic acid and trifluoroacetic acid. Salts with carboxylic acids; methanesulfonic acid, ethanesulfonic acid, benzenesulfonic acid, toluene-2-sulfonic acid, toluene-4-
Examples thereof include salts with sulfonic acids such as sulfonic acid, mesitylene sulfonic acid, and (2,4,6-trimethylbenzenesulfonic acid). Examples of salts in the acidic group include salts with alkali metals such as sodium and potassium. Salts with alkaline earth metals such as calcium and magnesium; ammonium salts; triethylamine, trimethylamine,
Examples thereof include salts with a nitrogen-containing organic base such as aniline, N, N-dimethylaniline, pyridine and dicyclohexylamine.
つぎに、本発明方法の実施態様について説明する。この
発明の製造法を示せば、つぎの通りである。Next, an embodiment of the method of the present invention will be described. The manufacturing method of the present invention is as follows.
なお、式中、Xはハロゲン原子を表わす。In the formula, X represents a halogen atom.
(1)アシル化 化学式[V]で表わされる化合物(シン異性体)または
その塩は、一般式[I]で表わされる化合物(シン異性
体)またはその塩と化学式[II]で表わされる化合物ま
たはその塩とを溶媒中、塩基の存在下または不存在下、
反応させることにより得ることができる。この反応に用
いられる溶媒としては、反応に悪影響を与えない限りい
かなるものでもよく、たとえば、水、アセトン、ジオキ
サン、アセトニトリル、クロロホルム、塩化メチレン、
塩化エチレン、テトラヒドロフラン、酢酸メチル、酢酸
エチル、N,N−ジメチルホルムアミド、N,N−ジメチルア
セトアミド、エチレングリコールモノメチルエーテル、
エチレングリコールジメチルエーテル、ジメチルスルホ
キシド、スルホランなどの溶媒またはこれらの溶媒を二
種以上混合したものが挙げられる。この反応に用いられ
る塩基としては、アルカリ金属の水酸化物、炭酸水素塩
もしくは炭酸塩などの無機塩基またはトリメチルアミ
ン、トリエチルアミン、トリブチルアミン、ピリジン、
メチルピリジン、N−メチルモルホリン、ルチジン、コ
リジンなどの第三級アミンが挙げられる。また化学式
[II]で表わされる化合物はそのアミノ基および/また
はカルボキシル基における反応性誘導体として使用する
こともでき、その反応性誘導体としては、たとえば、化
学式[II]で表わされる化合物とビス(トリメチルシリ
ル)アセトアミド、トリメチルシリルアセトアミド、ト
リメチルシリルクロリドなどのシリル化合物、三塩化リ
ン、 (CH3CH2)2PClなどのリン化合物または(C4H9)2SnClなど
のスズ化合物との反応により生成するシリル誘導体、リ
ン誘導体またはスズ誘導体など当該分野におけるアシル
化において繁用されるものが挙げられる。一般式[I]
で表される化合物(シン異性体)またはその塩の使用量
は、化学式[II]で表わされる化合物もしくはその塩ま
たはそれらの反応性誘導体に対して約1.0〜1.5倍モルで
ある。この反応は、通常−35℃〜25℃で、数分〜数時間
実施すればよい。 (1) Acylation A compound represented by the chemical formula [V] (syn isomer) or a salt thereof is a compound represented by the general formula [I] (syn isomer) or a salt thereof and a compound represented by the chemical formula [II] or The salt and the solvent in the presence or absence of a base,
It can be obtained by reacting. The solvent used in this reaction may be any solvent as long as it does not adversely affect the reaction, and examples thereof include water, acetone, dioxane, acetonitrile, chloroform, methylene chloride,
Ethylene chloride, tetrahydrofuran, methyl acetate, ethyl acetate, N, N-dimethylformamide, N, N-dimethylacetamide, ethylene glycol monomethyl ether,
Examples thereof include solvents such as ethylene glycol dimethyl ether, dimethyl sulfoxide, and sulfolane, or a mixture of two or more kinds of these solvents. Examples of the base used in this reaction include alkali metal hydroxides, inorganic bases such as hydrogen carbonate and carbonate, or trimethylamine, triethylamine, tributylamine, pyridine,
Examples include tertiary amines such as methylpyridine, N-methylmorpholine, lutidine and collidine. The compound represented by the chemical formula [II] can also be used as a reactive derivative at the amino group and / or the carboxyl group. Examples of the reactive derivative include the compound represented by the chemical formula [II] and bis (trimethylsilyl). ) Acetamide, trimethylsilylacetamide, silyl compounds such as trimethylsilyl chloride, phosphorus trichloride, (CH 3 CH 2) 2 silyl derivative formed by the reaction of a phosphorus compound or a (C 4 H 9) tin compounds such as 2 S n Cl such as PCl, frequently used in the acylation in the art such as phosphorus derivatives or tin derivatives The things that are done are listed. General formula [I]
The compound (syn isomer) or a salt thereof is used in an amount of about 1.0 to 1.5 times the molar amount of the compound represented by the chemical formula [II] or a salt thereof or a reactive derivative thereof. This reaction may be carried out usually at -35 ° C to 25 ° C for several minutes to several hours.
(2)脱水反応 ついで、アシル化により得られた化学式[V]で表わさ
れる化合物(シン異性体)またはその塩を、酸の存在下
または不存在下、脱水反応に付すことにより化学式[I
V]で表わされる化合物(シン異性体)またはその塩を
得ることができる。この反応は、好ましくは、溶媒中で
行われ、溶媒としては、反応に悪影響を与えない限りい
かなるものでもよく、たとえば、メタノール、エタノー
ル、アセトン、アセトニトリル、ニトロメタン、酢酸メ
チル、酢酸エチル、クロロホルム、塩化メチレン、テト
ラヒドロフラン、N,N−ジメチルホルムアミド、N,N−ジ
メチルアセトアミドなどの溶媒、これらの溶媒を二種以
上混合したものまたは水とこれらの溶媒を二種以上混合
したものが挙げられる。この反応に用いられる酸として
は、たとえば、塩酸、臭化水素酸、p−トルエンスルホ
ン酸、メシチレンスルホン酸などのプロトン酸;三弗化
硼素、塩化アルミニウム、塩化亜鉛などのルイス酸;三
弗化硼素・ジエチルエーテルなどのルイス酸の錯化合物
などが挙げられる。使用する溶媒が非水溶媒である場合
には、反応系内に適当な脱水剤、たとえば、無水硫酸マ
グネシウムまたはモレキュラーシーブなどを添加しても
よい。この反応は0℃〜30℃で、数分〜数時間実施すれ
ばよい。(2) Dehydration reaction Next, the compound (syn isomer) represented by the chemical formula [V] or a salt thereof obtained by acylation is subjected to a dehydration reaction in the presence or absence of an acid to give the chemical formula [I
A compound represented by V] (syn isomer) or a salt thereof can be obtained. This reaction is preferably carried out in a solvent, and any solvent may be used as long as it does not adversely influence the reaction, and examples thereof include methanol, ethanol, acetone, acetonitrile, nitromethane, methyl acetate, ethyl acetate, chloroform and chloride. Solvents such as methylene, tetrahydrofuran, N, N-dimethylformamide and N, N-dimethylacetamide, a mixture of two or more of these solvents, or a mixture of water and two or more of these solvents can be mentioned. Examples of the acid used in this reaction include protic acids such as hydrochloric acid, hydrobromic acid, p-toluenesulfonic acid and mesitylenesulfonic acid; Lewis acids such as boron trifluoride, aluminum chloride and zinc chloride; trifluoride. Examples thereof include complex compounds of Lewis acids such as boron and diethyl ether. When the solvent used is a non-aqueous solvent, a suitable dehydrating agent such as anhydrous magnesium sulfate or molecular sieve may be added to the reaction system. This reaction may be carried out at 0 ° C to 30 ° C for several minutes to several hours.
(3)ジオキサン付加体の生成 化学式[IV]で表わされる化合物(シン異性体)または
その塩を、溶媒の存在下または不存在下、ジオキサンで
処理することにより化学式[III]で表わされる化合物
(シン異性体)を得ることができる。溶媒としては、特
に限定されないが、たとえば、水とアセトニトリルなど
の親水性有機溶媒との混合溶媒が挙げられる。ここで使
用されるジオキサンの量は、化学式[IV]で表わされる
化合物(シン異性体)またはその塩に対して1〜10倍モ
ルである。この処理は酸性下で行うことが好ましく、最
適にはpH2.5〜3.0である。また、この処理は15℃〜30℃
で、10分〜10時間実施すればよい。(3) Formation of dioxane adduct A compound represented by the chemical formula [III] (syn isomer) or a salt thereof is treated with dioxane in the presence or absence of a solvent to obtain a compound represented by the chemical formula [III] ( Syn isomer) can be obtained. The solvent is not particularly limited, and examples thereof include a mixed solvent of water and a hydrophilic organic solvent such as acetonitrile. The amount of dioxane used here is 1 to 10 moles per mol of the compound represented by the chemical formula [IV] (syn isomer) or a salt thereof. This treatment is preferably carried out under acidic conditions, optimally pH 2.5-3.0. In addition, this treatment is 15 ℃ ~ 30 ℃
Then, it may be carried out for 10 minutes to 10 hours.
(4)ジオキサンの脱離 化学式[III]で表わされる化合物(シン異性体)のジ
オキサンを脱離する方法としては、酸・塩基処理、溶媒
処理などを単独または組み合わせて使用する方法が挙げ
られ、具体的には、(i)化学式[III]で表わされる
化合物(シン異性体)を塩基を用いて常法により塩に変
換した後、クロロホルム、塩化メチレン、酢酸エチルな
どの有機溶媒でジオキサンを抽出除去し、pH2.5〜3.0で
アセトンを加えアセトン付加体を得、ついでこのものを
メタノールで処理する方法、(ii)化学式[III]で表
わされる化合物(シン異性体)を酸(たとえば、塩酸な
ど)−有機溶媒の系にて処理し、酸付加塩(たとえば、
塩酸塩など)とした後、このものをアルコールもしくは
含水アルコールに溶解または懸濁させ、しかる後、脱酸
剤、たとえば、トリエチルアミン、ピリジン、プロピレ
ンオキサイドと反応させる方法、(iii)酸・塩基処理
を行う方法などがある。(4) Desorption of dioxane Examples of the method of removing dioxane of the compound (syn isomer) represented by the chemical formula [III] include a method of using acid / base treatment, a solvent treatment and the like, alone or in combination, Specifically, (i) a compound represented by the chemical formula [III] (syn isomer) is converted into a salt by a conventional method using a base, and then dioxane is extracted with an organic solvent such as chloroform, methylene chloride or ethyl acetate. Acetone adduct is obtained by adding acetone at pH 2.5 to 3.0, and then treating the product with methanol. (Ii) The compound represented by the chemical formula [III] (syn isomer) is treated with an acid (for example, hydrochloric acid). Etc.)-Treated with an organic solvent system, acid addition salt (for example,
(Hydrochloride, etc.), and then dissolving or suspending this in alcohol or hydrous alcohol, and then reacting with a deoxidizing agent such as triethylamine, pyridine, propylene oxide, (iii) acid / base treatment There are ways to do it.
(i)において用いられる塩基としては、アルカリ金属
の水酸化物、炭酸塩もしくは炭酸水素塩などの無機塩基
またはトリエチルアミン、ピリジンなどの有機塩基が挙
げられる。(ii)で用いられる有機溶媒としては、反応
に悪影響を与えない限りいかなるものでもよく、たとえ
ば、アセトン、アセトニトリル、エタノールなどが挙げ
られる。(iii)で用いられる酸としては、塩酸、硫酸
などが挙げられ、また塩基としては、(i)と同様な無
機または有機の塩基が挙げられる。Examples of the base used in (i) include inorganic bases such as alkali metal hydroxides, carbonates and hydrogen carbonates, and organic bases such as triethylamine and pyridine. The organic solvent used in (ii) may be any organic solvent as long as it does not adversely affect the reaction, and examples thereof include acetone, acetonitrile, ethanol and the like. Examples of the acid used in (iii) include hydrochloric acid and sulfuric acid, and examples of the base include the same inorganic or organic bases as in (i).
つぎに、原料として用いられる一般式[I]の化合物
(シン異性体)またはその塩の製造法について説明す
る。Next, a method for producing the compound of formula [I] (syn isomer) or a salt thereof used as a raw material will be described.
これらの化合物は、たとえば、つぎに示す製造法によっ
て容易に製造することができる。さらに、具体的には、
特開昭60-199894号記載の方法で製造することができ
る。These compounds can be easily produced, for example, by the production method shown below. Furthermore, specifically,
It can be produced by the method described in JP-A-60-199894.
なお、式中、Xはハロゲン原子を表わす。In the formula, X represents a halogen atom.
[発明の効果] かくして、本発明の方法を実施することにより、化学式
[IV]で表わされる化合物(シン異性体)またはその塩
を工業的に高収率でかつ高純度に得ることができる。 [Effects of the Invention] Thus, by carrying out the method of the present invention, the compound (syn isomer) represented by the chemical formula [IV] or a salt thereof can be industrially obtained in high yield and high purity.
[実施例] つぎに、本発明を参考例および実施例を挙げて説明する
が、本発明はこれに限定されるものではない。EXAMPLES Next, the present invention will be described with reference to Reference Examples and Examples, but the present invention is not limited thereto.
参考例1 (1)水330mlに亜硝酸ナトリウム38.0gおよび3−オキ
ソチオ酪酸−S−メチルエステル66.1gを加え、5〜8
℃で撹拌下に4N−硫酸210mlを30分を要して滴下する。
滴下終了後、同温度で30分間反応させた後、反応液を酢
酸エチル500ml中に導入する。有機層を分取し、水500ml
で洗浄した後、無水硫酸マグネシウムで乾燥させ、減圧
下に溶媒を留去する。得られた残留物を炭酸ナトリウム
106gを含む水溶液650mlに溶解させた後、メタノール150
mlを加える。この溶液にジメチル硫酸75.7gを15〜20℃
で滴下した後、同温度で2時間反応させる。ついで、反
応液を酢酸エチル1中に導入した後、有機層を分取
し、水300mlで洗浄した後、無水硫酸マグネシウムで乾
燥させる。減圧下に溶媒を留去し、得られた残留物を減
圧蒸留すれば、沸点80〜86℃/2mmHgを示す2−メトキシ
イミノ−3−オキソチオ酪酸−S−メチルエステル(シ
ンおよびアンチ体の混合物)60.4g(収率68.9%)を得
る。Reference Example 1 (1) To 330 ml of water, 38.0 g of sodium nitrite and 66.1 g of 3-oxothiobutyric acid-S-methyl ester were added to give 5 to 8
210 ml of 4N-sulfuric acid was added dropwise over 30 minutes with stirring at ℃.
After the dropping is completed, the reaction is carried out at the same temperature for 30 minutes, and then the reaction solution is introduced into 500 ml of ethyl acetate. Separate the organic layer and add 500 ml of water.
After washing with, dried over anhydrous magnesium sulfate, the solvent is distilled off under reduced pressure. The residue obtained is sodium carbonate
After dissolving in 650 ml of an aqueous solution containing 106 g, methanol 150
Add ml. To this solution, add 75.7g of dimethylsulfate to 15 ~ 20 ℃.
Then, the mixture is reacted at the same temperature for 2 hours. Then, the reaction solution is introduced into ethyl acetate 1, the organic layer is separated, washed with 300 ml of water, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was distilled under reduced pressure to give 2-methoxyimino-3-oxothiobutyric acid-S-methyl ester (a mixture of syn and anti forms) having a boiling point of 80 to 86 ° C / 2 mmHg. ) 60.4 g (yield 68.9%) are obtained.
(2)2−メトキシイミノ−3−オキソチオ酪酸−S−
メチルエステル(シンおよびアンチ体の混合物)10.0g
を1,4−ジオキサン150mlに溶解させ、ピリジニウムハイ
ドロブロマイド・パーブロマイド20.1gを加えて、室温
で4時間反応させる。ついで、減圧下に溶媒を留去し、
得られた残留物に酢酸エチル100mlおよび水100mlを加え
る。有機層を分取し、5%亜硫酸水素ナトリウム水溶液
100ml、水100mlおよび飽和食塩水100mlで順次洗浄した
後、無水硫酸マグネシウムで乾燥させる。減圧下に溶媒
を留去すれば、4−ブロモ−2−メトキシイミノ−3−
オキソチオ酪酸−S−メチルエステル(シンおよびアン
チ体の混合物)11.6g(収率80.0%)を得る。(2) 2-methoxyimino-3-oxothiobutyric acid-S-
Methyl ester (mixture of syn and anti forms) 10.0g
Is dissolved in 150 ml of 1,4-dioxane, 20.1 g of pyridinium hydrobromide perbromide is added, and the mixture is reacted at room temperature for 4 hours. Then, the solvent was distilled off under reduced pressure,
100 ml of ethyl acetate and 100 ml of water are added to the residue obtained. The organic layer is separated and a 5% aqueous solution of sodium hydrogen sulfite is added.
The extract is washed successively with 100 ml, 100 ml of water and 100 ml of saturated saline, and then dried over anhydrous magnesium sulfate. If the solvent is distilled off under reduced pressure, 4-bromo-2-methoxyimino-3-
11.6 g (yield 80.0%) of oxothiobutyric acid-S-methyl ester (mixture of syn and anti forms) is obtained.
(3)(i)4−ブロモ−2−メトキシイミノ−3−オ
キソチオ酪酸−S−メチルエステル(シンおよびアンチ
混合物)50.0gをアセトン250mlに溶解させ、−25〜−20
℃でチオ尿素7.5gを1時間を要して加える。同温度で2
時間反応させ、析出晶を濾取した後、アセトン50mlで洗
浄すれば、2−(2−アミノ−4−ヒドロキシ−2−チ
アゾリン−4−イル)−2−(シン)−メトキシイミノ
チオ酢酸−S−メチルエステルの臭化水素酸30.9g(収
率47.5%)を得る。(3) (i) 4-bromo-2-methoxyimino-3-oxothiobutyric acid-S-methyl ester (syn and anti-mixture) (50.0 g) was dissolved in acetone (250 ml) to give -25 to -20.
Add 7.5 g of thiourea over 1 hour at 0 ° C. 2 at the same temperature
After reacting for a period of time, the precipitated crystals were collected by filtration and washed with 50 ml of acetone to give 2- (2-amino-4-hydroxy-2-thiazolin-4-yl) -2- (syn) -methoxyiminothioacetic acid- 30.9 g (yield 47.5%) of hydrobromic acid of S-methyl ester is obtained.
IR(KBr)cm-1;νC=O1650 (ii)上の(i)で得られた濾液を減圧下に濃縮し、得
られた残留物を酢酸エチル200mlに溶解させる。つい
で、水200mlで洗浄した後、無水硫酸マグネシウムで乾
燥する。0〜5℃で乾燥塩化水素2.0gを導入し、室温で
5時間反応させた後、水100mlで2回洗浄し、無水硫酸
マグネシウムで乾燥する。減圧下に溶媒を留去し、得ら
れた残留物をアセトン120mlに溶解させ、−25〜−20℃
でチオ尿素3.0gを1時間を要して加える。同温度で2時
間反応させ、析出晶を濾取し、アセトン20mlで洗浄すれ
ば、2−(2−アミノ−4−ヒドロキシ−2−チアゾリ
ン−4−イル)−2−(シン)−メトキシイミノチオ酢
酸−S−メチルエステルの臭化水素酸塩10.1g(収率15.
5%)を得る。IR (KBr) cm -1 ; ν C = O 1650 (ii) The filtrate obtained in (i) above is concentrated under reduced pressure and the residue obtained is dissolved in 200 ml of ethyl acetate. Then, it is washed with 200 ml of water and dried over anhydrous magnesium sulfate. 2.0 g of dry hydrogen chloride was introduced at 0 to 5 ° C., reacted at room temperature for 5 hours, washed twice with 100 ml of water, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, the resulting residue was dissolved in 120 ml of acetone, and the temperature was -25 to -20 ° C.
Then, 3.0 g of thiourea is added over 1 hour. After reacting for 2 hours at the same temperature, the precipitated crystals were collected by filtration and washed with 20 ml of acetone to give 2- (2-amino-4-hydroxy-2-thiazolin-4-yl) -2- (syn) -methoxyimino. 10.1 g of hydrobromide of thioacetic acid-S-methyl ester (yield 15.
5%).
IR(KBr)cm-1;νC=O1650 (4)2−(2−アミノ−4−ヒドロキシ−2−チアゾ
リン−4−イル)−2−(シン)−メトキシイミノチオ
酢酸−S−メチルエステルの臭化水素酸塩20.0gを無水
塩化メチレン100mlに懸濁させ、0〜5℃で塩素8.6gを
含む無水塩化メチレン溶液100mlを10分を要して滴下す
る。ついで、同温度で30分間反応させた後、析出晶を濾
取し、無水塩化メチレン20mlで2回洗浄すれば、融点12
0〜122℃(分解)を示す2−(2−アミノ−4−ヒドロ
キシ−2−チアゾリン−4−イル)−2−(シン)−メ
トキシイミノ酢酸クロリドの臭化水素酸塩14.6g(収率7
5.7%)を得る。IR (KBr) cm -1 ; ν C = O 1650 (4) 2- (2-amino-4-hydroxy-2-thiazolin-4-yl) -2- (syn) -methoxyiminothioacetic acid-S-methyl 20.0 g of the ester hydrobromide is suspended in 100 ml of anhydrous methylene chloride and 100 ml of an anhydrous methylene chloride solution containing 8.6 g of chlorine is added dropwise at 0-5 ° C. over 10 minutes. Then, after reacting for 30 minutes at the same temperature, the precipitated crystals are collected by filtration and washed twice with 20 ml of anhydrous methylene chloride to give a melting point of 12
1-4.6 g (yield of 2- (2-amino-4-hydroxy-2-thiazolin-4-yl) -2- (syn) -methoxyiminoacetic acid chloride hydrobromide showing 0-122 ° C (decomposition) 7
5.7%).
IR(KBr)cm-1;νC=O1780 実施例1 7β−アミノ−3−[(5−メチル−2H−テトラゾール
−2−イル)メチル]−Δ3−セフェム−4−カルボン
酸10.00gを無水塩化メチレン100mlに懸濁させ、0〜5
℃でトリメチルシリルクロリド9.16gを加え、さらに、
同温度でトリエチルアミン8.53gを30分を要して滴下
し、同温度で1時間反応させる。反応液を−30℃に冷却
し、2−(2−アミノ−4−ヒドロキシ−2−チアゾリ
ン−4−イル)−2−(シン)−メトキシイミノ酢酸ク
ロリドの臭化水素酸塩12.87gを−30〜−20℃で10分を要
して加えた後、0〜5℃で1.5時間反応させる。つい
で、水50mlを加えて水層を分取した後、アセトニトリル
50mlを加える。炭酸ナトリウムでpH2.7に調整し、不溶
物を濾別した後、濾液にジオキサン16mlを加え、23〜27
℃で1時間、さらに18〜22℃で1時間攪拌する。得られ
た結晶を濾取すれば、融点183〜185℃(分解)を示す7
β−[(Z)−2−(2−アミノチアゾール−4−イ
ル)−2−メトキシイミノアセトアミド]−3−[(5
−メチル−2H−テトラゾール−2−イル)メチル]−Δ
3−セフェム−4−カルボン酸のジオキサン付加体15.15
g(収率79.2%)を得る。IR (KBr) cm −1 ; ν C═O 1780 Example 1 7β-Amino-3-[(5-methyl-2H-tetrazol-2-yl) methyl] -Δ 3 -cephem-4-carboxylic acid 10.00 g Suspended in 100 ml of anhydrous methylene chloride, 0-5
9.16 g of trimethylsilyl chloride was added at ℃,
At the same temperature, 8.53 g of triethylamine was added dropwise over 30 minutes, and the reaction was carried out at the same temperature for 1 hour. The reaction solution was cooled to −30 ° C., and 12.87 g of 2- (2-amino-4-hydroxy-2-thiazolin-4-yl) -2- (syn) -methoxyiminoacetic acid chloride hydrobromide was added. After adding at 30 to -20 ° C over 10 minutes, the mixture is reacted at 0 to 5 ° C for 1.5 hours. Then, 50 ml of water was added to separate the aqueous layer, and then acetonitrile was used.
Add 50 ml. The pH was adjusted to 2.7 with sodium carbonate, the insoluble matter was filtered off, 16 ml of dioxane was added to the filtrate, and 23 to 27
Stir at 1 ° C for 1 hour, then at 18-22 ° C for 1 hour. The crystals obtained have a melting point of 183 to 185 ° C. (decomposition) when filtered.
β-[(Z) -2- (2-aminothiazol-4-yl) -2-methoxyiminoacetamide] -3-[(5
-Methyl-2H-tetrazol-2-yl) methyl] -Δ
Dioxane adduct of 3 -cephem-4-carboxylic acid 15.15
g (yield 79.2%) is obtained.
IR(KBr)cm-1;νC=O1770,1675〜1610 NMR(d6‐DMSO)δ値; 2.47(3H,s,−CH3),3.46(2H,bs,C2−H),3.58(8H,
s, ),3.86(3H,s,−OCH3),5.15(1H,d,J=5Hz,C6−H),
5.64(2H,bs,C3−CH2),5.83(1H,dd,J=5Hz,8Hz,C7−
H),6.74(1H,s,チアゾールC5−H),7.15(3H,bs,−N
H3 ),9.59(1H,d,J=8Hz,−CONH−) 実施例2 (1)7β−[(Z)−2−(2−アミノチアゾール−
4−イル)−2−メトキシイミノアセトアミド]−3−
[(5−メチル−2H−テトラゾール−2−イル)メチ
ル]−Δ3−セフェム−4−カルボン酸のジオキサン付
加体10.00gを水25mlに懸濁させ、18〜22℃で炭酸水素ナ
トリウム1.48gを10分を要して添加して溶解させる。つ
いで、塩化メチレン50mlを加えて10分間攪拌した後、水
層を分取する。再び塩化メチレン50mlを加えて10分間攪
拌した後、水層を分取する。ついで、アセトン38mlを加
えて2N−塩酸でpH5.0に調整し、活性炭500mgを添加して
10分間攪拌した後、セライト濾過する。濾滓をアセトン
7mlおよび水5mlの混合溶媒で洗浄し、濾液を23〜27℃で
2N−塩酸でpH2.7に調整した後、同温度で30分間、さら
に18〜22℃で30分間攪拌する。得られた結晶を濾過し、
50%アセトン5mlおよび水15mlで2回ずつ順次洗浄した
後乾燥すれば、融点149〜153℃(分解)を示す7β−
[(Z)−2−(2−アミノチアゾール−4−イル)−
2−メトキシイミノアセトアミド]−3−[(5−メチ
ル−2H−テトラゾール−2−イル)メチル]−Δ3−セ
フェム−4−カルボン酸の1/4アセトン付加体6.86g(収
率78.9%)を得る。IR (KBr) cm-1; ΝC = O1770, 1675 to 1610 NMR (d6-DMSO) δ value; 2.47 (3H, s, -CH3), 3.46 (2H, bs, C2-H), 3.58 (8H,
s,), 3.86 (3H, s, −OCH3), 5.15 (1H, d, J = 5Hz, C6-H),
5.64 (2H, bs, C3-CH2), 5.83 (1H, dd, J = 5Hz, 8Hz, C7−
H), 6.74 (1H, s, thiazole CFive-H), 7.15 (3H, bs, -N
H3 ), 9.59 (1H, d, J = 8Hz, -CONH-) Example 2 (1) 7β-[(Z) -2- (2-aminothiazole-
4-yl) -2-methoxyiminoacetamide] -3-
[(5-Methyl-2H-tetrazol-2-yl) meth
] -Δ3-Cephem-4-carboxylic acid with dioxane
Suspend 10.00 g of the added body in 25 ml of water and add sodium bicarbonate at 18-22 ° C.
Add 1.48 g of thorium over 10 minutes to dissolve. One
Then, add 50 ml of methylene chloride and stir for 10 minutes.
Separate layers. Add 50 ml of methylene chloride again and stir for 10 minutes.
After stirring, the aqueous layer is separated. Then add 38 ml of acetone.
Adjust the pH to 5.0 with 2N-hydrochloric acid and add 500 mg of activated carbon.
After stirring for 10 minutes, it is filtered through Celite. Acetone from the filter cake
Wash with a mixed solvent of 7 ml and 5 ml of water, and filter the filtrate at 23-27 ° C.
After adjusting the pH to 2.7 with 2N-hydrochloric acid, add 30 minutes at the same temperature.
Stir for 30 minutes at 18-22 ° C. The obtained crystals are filtered,
Washed sequentially with 5% 50% acetone and 15 ml water twice each
If dried afterwards, 7β- showing a melting point of 149-153 ° C (decomposition)
[(Z) -2- (2-aminothiazol-4-yl)-
2-Methoxyiminoacetamide] -3-[(5-methyl
L-2H-tetrazol-2-yl) methyl] -Δ3-C
6.86 g of 1/4 acetone adduct of fem-4-carboxylic acid
Rate 78.9%).
IR(KBr)cm-1;νC=O1770,1690〜1610 NMR(d6‐DMSO)δ値; 2.09(1.5H,s,1/4アセトン),2.47(3H,s,−CH3),3.46
(2H,bs,C2−H),3.85(3H,s,−OCH3),5.15(1H,d,J
=5Hz,C6−H),5.41(3H,bs,−NH3 ),5.64(2H,bs,C
3−CH2),5.81(1H,dd,J=5Hz,8Hz,C7−H),6.71(1H,
s,チアゾールC5−H),9.64(1H,d,J=8Hz,−CONH−) (2)(1)で得られた7β−[(Z)−2−(2−ア
ミノチアゾール−4−イル)−2−メトキシイミノアセ
トアミド]−3−[(5−メチル−2H−テトラゾール−
2−イル)メチル]−Δ3−セフェム−4−カルボン酸
の1/4アセトン付加体5.00gをメタノール10mlに懸濁さ
せ、18〜22℃で1時間攪拌する。得られた結晶を濾取
し、メタノール3.8mlで洗浄した後乾燥すれば、7β−
[(Z)−2−(2−アミノチアゾール−4−イル)−
2−メトキシイミノアセトアミド]−3−[(5−メチ
ル−2H−テトラゾール−2−イル)メチル]−Δ3−セ
フェム−4−カルボン酸4.00g(収率82.3%)を得る。IR (KBr) cm-1; ΝC = O1770, 1690-1610 NMR (d6-DMSO) δ value; 2.09 (1.5H, s, 1/4 acetone), 2.47 (3H, s, -CH3), 3.46
(2H, bs, C2-H), 3.85 (3H, s, -OCH3), 5.15 (1H, d, J
= 5Hz, C6-H), 5.41 (3H, bs, -NH3 ), 5.64 (2H, bs, C
3-CH2), 5.81 (1H, dd, J = 5Hz, 8Hz, C7-H), 6.71 (1H,
s, thiazole CFive-H), 9.64 (1H, d, J = 8Hz, -CONH-) (2) 7β-[(Z) -2- (2-a
Minothiazol-4-yl) -2-methoxyiminoacetate
Toamido] -3-[(5-methyl-2H-tetrazole-
2-yl) methyl] -Δ3-Cephem-4-carboxylic acid
1/4 acetone adduct of 5.00 g was suspended in 10 ml of methanol.
And stir at 18-22 ° C for 1 hour. The crystals obtained are collected by filtration
Then, if it is washed with 3.8 ml of methanol and then dried, 7β-
[(Z) -2- (2-aminothiazol-4-yl)-
2-Methoxyiminoacetamide] -3-[(5-methyl
L-2H-tetrazol-2-yl) methyl] -Δ3-C
4.00 g (82.3% yield) of fem-4-carboxylic acid is obtained.
NMR(d6‐DMSO)δ値; 2.57(3H,s,−CH3),3.47(2H,bs,C2−H),3.86(3H,
s,−OCH3),5.15(1H,d,J=5Hz,C6−H),5.65(2H,bs,
C3−CH2),5.81(1H,dd,J=5Hz,8Hz,C7−H),6.73(1
H,s,チアゾールC5−H),6.92(3H,bs,−NH3 ),9.61
(1H,d,J=8Hz,−CONH−) 実施例3 (1)7β−[(Z)−2−(2−アミノチアゾール−
4−イル)−2−メトキシイミノアセトアミド]−3−
[(5−メチル−2H−テトラゾール−2−イル)メチ
ル]−Δ3−セフェム−4−カルボン酸のジオキサン付
加体10.00gを90%エタノール30mlに懸濁させ、23〜27℃
で濃塩酸2.1mlを加えて溶解させ、活性炭1.00gを加えて
10分間攪拌する。ついで、セライト濾過し、濾滓を90%
エタノール15mlで洗浄した後、濾液に濃塩酸2.1mlを加
えて23〜27℃で5時間攪拌する。得られた結晶を濾取
し、90%エタノール5mlで洗浄し乾燥すれば、融点156〜
158℃(分解)を示す7β−[(Z)−2−(2−アミ
ノチアゾール−4−イル)−2−メトキシイミノアセト
アミド]−3−[(5−メチル−2H−テトラゾール−2
−イル)メチル]−Δ3−セフェム−4−カルボン酸の
塩酸の塩酸塩6.84g(収率75.2%)を得る。NMR (d6-DMSO) δ value; 2.57 (3H, s, -CH3), 3.47 (2H, bs, C2-H), 3.86 (3H,
s, −OCH3), 5.15 (1H, d, J = 5Hz, C6-H), 5.65 (2H, bs,
C3-CH2), 5.81 (1H, dd, J = 5Hz, 8Hz, C7-H), 6.73 (1
H, s, thiazole CFive-H), 6.92 (3H, bs, -NH3 ), 9.61
(1H, d, J = 8Hz, -CONH-) Example 3 (1) 7β-[(Z) -2- (2-aminothiazole-
4-yl) -2-methoxyiminoacetamide] -3-
[(5-Methyl-2H-tetrazol-2-yl) meth
] -Δ3-Cephem-4-carboxylic acid with dioxane
Suspend 10.00g of added body in 30ml of 90% ethanol, 23-27 ℃
Then add 2.1 ml of concentrated hydrochloric acid to dissolve and add 1.00 g of activated carbon.
Stir for 10 minutes. Then, it is filtered through Celite and the filter cake is 90%
After washing with 15 ml of ethanol, add 2.1 ml of concentrated hydrochloric acid to the filtrate.
Stir at 23-27 ° C for 5 hours. The crystals obtained are collected by filtration
Then, wash with 5 ml of 90% ethanol and dry. Melting point 156-
7β-[(Z) -2- (2-ami) showing 158 ° C (decomposition)
Nothiazol-4-yl) -2-methoxyiminoaceto
Amido] -3-[(5-methyl-2H-tetrazole-2
-Yl) methyl] -Δ3-Of cephem-4-carboxylic acid
6.84 g (75.2% yield) of hydrochloric acid hydrochloride is obtained.
IR(KBr)cm-1;νC=O1770,1720,1680〜1620 NMR(d6‐DMSO)δ値; 2.48(3H,s,−CH3),3.61(2H,bs,C2−H),3.99(3H,
s,−OCH3),5.20(1H,d,J=5Hz,C6−H),5.68(2H,bs,
C3−CH2),5.81(1H,dd,J=5Hz,8Hz,C7−H),6.41(3
H,bs,−NH3 ),6.97(1H,s,チアゾールC5−H),9.95
(1H,d,J=8Hz,−CONH−) (2)7β−[(Z)−2−(2−アミノチアゾール−
4−イル)−2−メトキシイミノアセトアミド]−3−
[(5−メチル−2H−テトラゾール−2−イル)メチ
ル]−Δ3−セフェム−4−カルボン酸の塩酸塩5.20gを
11mlのメタノールに溶解させ、25℃でプロピレンオキサ
イド1.17gを添加した後、23〜27℃で1.5時間攪拌する。
得られた結晶を濾取し、メタノール3mlで2回洗浄し乾
燥すれば、7β−[(Z)−2−(2−アミノチアゾー
ル−4−イル)−2−メトキシイミノアセトアミド]−
3−[(5−メチル−2H−テトラゾール−2−イル)メ
チル]−Δ3−セフェム−4−カルボン酸3.61g(収率7
4.7%)を得る。IR (KBr) cm-1; ΝC = O1770, 1720, 1680-1620 NMR (d6-DMSO) δ value; 2.48 (3H, s, -CH3), 3.61 (2H, bs, C2-H), 3.99 (3H,
s, −OCH3), 5.20 (1H, d, J = 5Hz, C6-H), 5.68 (2H, bs,
C3-CH2), 5.81 (1H, dd, J = 5Hz, 8Hz, C7-H), 6.41 (3
H, bs, −NH3 ), 6.97 (1H, s, thiazole CFive-H), 9.95
(1H, d, J = 8Hz, -CONH-) (2) 7β-[(Z) -2- (2-aminothiazole-
4-yl) -2-methoxyiminoacetamide] -3-
[(5-Methyl-2H-tetrazol-2-yl) meth
] -Δ3-5.20 g of cephem-4-carboxylic acid hydrochloride
Dissolve it in 11 ml of methanol and propylene oxide at 25 ℃.
After adding 1.17 g of id, stir at 23-27 ° C for 1.5 hours.
The crystals obtained are collected by filtration, washed twice with 3 ml of methanol and dried.
If dried, 7β-[(Z) -2- (2-aminothiazo
L-4-yl) -2-methoxyiminoacetamide]-
3-[(5-methyl-2H-tetrazol-2-yl) me
Chill] -Δ3-Cephem-4-carboxylic acid 3.61 g (yield 7
4.7%).
なお、この化合物の物性(NMR)は、実施例2(2)で
得られたものと一致した。The physical properties (NMR) of this compound were the same as those obtained in Example 2 (2).
実施例4 7β−[(Z)−2−(2−アミノチアゾール−4−イ
ル)−2−メトキシイミノアセトアミド]−3−[(5
−メチル−2H−テトラゾール−2−イル)メチル]−Δ
3−セフェム−4−カルボン酸のジオキサン付加体3.50g
を水21mlに懸濁させ、13〜17℃で炭酸水素ナトリウム52
0mgを10分を要して加えて溶解させる。ついで、2N−塩
酸でpH2.7に調整し、同温度で10分間攪拌する。得られ
た結晶を濾取し、水5mlで2回洗浄し乾燥すれば、7β
−[(Z)−2−(2−アミノチアゾール−4−イル)
−2−メトキシイミノアセトアミド]−3−[(5−メ
チル−2H−テトラゾール−2−イル)メチル]−Δ3−
セフェム−4−カルボン酸2.35g(収率79.4%)を得
る。Example 4 7β-[(Z) -2- (2-aminothiazol-4-yl) -2-methoxyiminoacetamide] -3-[(5
-Methyl-2H-tetrazol-2-yl) methyl] -Δ
3.50 g of dioxane adduct of 3 -cephem-4-carboxylic acid
Is suspended in 21 ml of water, and sodium hydrogen carbonate 52
Add 0 mg over 10 minutes to dissolve. Then, the pH is adjusted to 2.7 with 2N hydrochloric acid, and the mixture is stirred at the same temperature for 10 minutes. The crystals obtained were collected by filtration, washed twice with 5 ml of water and dried to give 7β.
-[(Z) -2- (2-aminothiazol-4-yl)
2-Methoxyiminoacetamido] -3-[(5-methyl-2H-tetrazol-2-yl) methyl] -Δ 3 −
2.35 g (yield 79.4%) of cephem-4-carboxylic acid are obtained.
なお、この化合物の物性(NMR)は、実施例2(2)で
得られたものと一致した。The physical properties (NMR) of this compound were the same as those obtained in Example 2 (2).
───────────────────────────────────────────────────── フロントページの続き 審査官 弘實 謙二 (56)参考文献 特開 昭57−99592(JP,A) 特開 昭56−61388(JP,A) 特開 昭52−83574(JP,A) ─────────────────────────────────────────────────── ─── Continuation of front page Examiner Kenji Hiromi (56) References JP-A-57-99592 (JP, A) JP-A-56-61388 (JP, A) JP-A-52-83574 (JP, A)
Claims (1)
式 で表わされる化合物もしくはその塩またはそれらの反応
性誘導体と反応させた後、脱水反応に付し、ついでジオ
キサンで処理して化学式 で表わされるジオキサン付加化合物(シン異性体)を単
離し、この化合物からジオキサンを脱離させることを特
徴とするつぎの化学式 で表わされる化合物(シン異性体)またはその塩の製造
法。1. A general formula [In the formula, X represents a halogen atom. ] The compound (syn isomer) represented by After reacting with a compound represented by or a salt thereof or a reactive derivative thereof, it is subjected to dehydration reaction and then treated with dioxane to obtain a compound represented by the chemical formula: A dioxane addition compound (syn isomer) represented by is isolated, and dioxane is eliminated from this compound. A method for producing a compound represented by (syn isomer) or a salt thereof.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60206231A JPH07116200B2 (en) | 1985-09-20 | 1985-09-20 | Cephalosporin manufacturing method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60206231A JPH07116200B2 (en) | 1985-09-20 | 1985-09-20 | Cephalosporin manufacturing method |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP30282094A Division JP2599105B2 (en) | 1994-11-11 | 1994-11-11 | Dioxane adduct |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6267088A JPS6267088A (en) | 1987-03-26 |
| JPH07116200B2 true JPH07116200B2 (en) | 1995-12-13 |
Family
ID=16519929
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP60206231A Expired - Lifetime JPH07116200B2 (en) | 1985-09-20 | 1985-09-20 | Cephalosporin manufacturing method |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH07116200B2 (en) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5283574A (en) * | 1976-01-01 | 1977-07-12 | Lilly Co Eli | Sephamandol salt crystal containing dioxane |
| US4252951A (en) * | 1979-10-09 | 1981-02-24 | Eli Lilly And Company | Isolation of syn-7-(2-amino-4-thiazolyl)-(methoxyimino)acetamido-3-acetoxymethyl-3-cephem-4-carboxylic acid |
| JPS5779592A (en) * | 1980-12-19 | 1982-05-18 | Laurel Bank Machine Co | Bank note containing box with reject pool unit in bank note payout machine |
-
1985
- 1985-09-20 JP JP60206231A patent/JPH07116200B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6267088A (en) | 1987-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0189287B1 (en) | Novel b-lactam antibiotics | |
| JPH02311483A (en) | Preparation of ceftriaxone | |
| US4714760A (en) | Cephalosporin intermediates | |
| US4608373A (en) | Cephem compounds | |
| JPH027315B2 (en) | ||
| JPH0553798B2 (en) | ||
| EP0142274A2 (en) | Cephalosporin compounds and salts thereof, their production, and medicaments containing them | |
| JP4856795B2 (en) | Novel salts in the production of cephalosporin antibiotics. | |
| JPH07116200B2 (en) | Cephalosporin manufacturing method | |
| JPH0134227B2 (en) | ||
| JP2599105B2 (en) | Dioxane adduct | |
| US4868294A (en) | Process for preparing cephalosporin intermediates | |
| KR890002107B1 (en) | Method for preparing cephalosporin derivative | |
| JPH0322392B2 (en) | ||
| JPH08831B2 (en) | Purification method of cephalosporins | |
| CA1161429A (en) | 2-(2-aminothiazol-4-yl)-n-(imidazolidin-2-on-1-yl)-2- imino-acetylaminocephalosporanic acids in pure syn- form, a process for their production and syn-acid used in such a process | |
| KR100841044B1 (en) | Process for preparing cephalosporin compound | |
| KR0157589B1 (en) | New cephalosporin antibiotics and preparation method thereof | |
| JP2859630B2 (en) | Method for producing thiadiazolylacetic acid derivative and intermediate thereof | |
| JP2904810B2 (en) | 7-thiazolylacetamide-3-propenylcephem derivative | |
| JPH0251433B2 (en) | ||
| JPS6126999B2 (en) | ||
| JPH06206886A (en) | Cephem compound, its production and medicine comprising the same compound | |
| SU882412A3 (en) | Method of preparing derivatives of 7-/2-(2-aminothizol-4-yl)-2-methoxyiminoacetamido/3-acetoxymethyl-3-cephem-4-carboxalic acid in form of sin-isomers | |
| KR790001175B1 (en) | Process for preparing 7-amino cephalosporanic acid and their derivatives |